An in vivo mouse model of metastatic human thyroid cancer

Thyroid

Volumn 24, Issue 4, 2014, Pages 695-704

  Zhang, Lisa ^a   Gaskins, Kelli ^a   Yu, Zhiya ^a   Xiong, Yin ^a   Merino, Maria J ^a   Kebebew, Electron ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VEMURAFENIB; INDOLE DERIVATIVE; SULFONAMIDE;

ANAPLASTIC THYROID CANCER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE METASTASIS; CANCER CELL CULTURE; COMPUTER PROGRAM; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; IMAGING SYSTEM; IN VIVO STUDY; LUNG METASTASIS; MALE; MOUSE; MOUSE MODEL; NONHUMAN; PRIORITY JOURNAL; THYROID FOLLICULAR CARCINOMA; THYROID PARAFOLLICULAR CELL; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT; ADENOCARCINOMA; ANIMAL; BONE TUMOR; CANCER TRANSPLANTATION; DISEASE MODEL; GENETICS; LUNG NEOPLASMS; NONOBESE DIABETIC MOUSE; ONCOCYTOMA; PATHOLOGY; SCID MOUSE; SECONDARY; THYROID TUMOR; TUMOR CELL LINE; XENOGRAFT;

ADENOCARCINOMA, FOLLICULAR; ADENOMA, OXYPHILIC; ANIMALS; BONE NEOPLASMS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FEMALE; HETEROGRAFTS; HUMANS; INDOLES; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASM TRANSPLANTATION; SULFONAMIDES; THYROID NEOPLASMS;

EID: 84898484091     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2013.0149     Document Type: Article

References (25)

1. Howlader N NA, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA, Edwards BK (eds) 2011 SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD, based on November 2010 SEER data submission, posted to the SEER Web site. http://seer.cancer .gov/archive/csr/1975-2008/
2. Ruegemer JJ, Hay ID, Bergstralh EJ, Ryan JJ, Offord KP, Gorman CA 1988 Distant metastases in differentiated thyroid carcinoma: A multivariate analysis of prognostic variables. J Clin Endocrinol Metab 67:501-508
3. Shaha AR 2012 Recurrent differentiated thyroid cancer. Endocr Pract 18:600-603
4. Clark OH 1996 Predictors of thyroid tumor aggressiveness. West J Med 165:131-138
5. Hundahl SA, Fleming ID, Fremgen AM, Menck HR 1998A National Cancer Data Base report on 53, 856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see comments]. Cancer 83:2638-2648
6. Smallridge RC, Copland JA 2010 Anaplastic thyroid carcinoma: Pathogenesis and emerging therapies. Clin Oncol (R Coll Radiol) 22:486-497
7. McIver B, Hay ID, Giuffrida DF, Dvorak CE, Grant CS, Thompson GB, van Heerden JA, Goellner JR 2001 Anaplastic thyroid carcinoma: A 50-year experience at a single institution. Surgery 130:1028-1034
8. Zhu XG, Zhao L, Willingham MC, Cheng SY 2010 Thyroid hormone receptors are tumor suppressors in a mouse model of metastatic follicular thyroid carcinoma. Oncogene 29:1909-1919
9. Knostman KA, Jhiang SM, Capen CC 2007 Genetic alterations in thyroid cancer: The role of mouse models. Vet Pathol 44:1-14
10. KimWG, Guigon CJ, Fozzatti L, Park JW, Lu C, Willingham MC, Cheng SY 2012 SKI-606, an Src inhibitor, reduces tumor growth, invasion, and distant metastasis in a mouse model of thyroid cancer. Clin Cancer Res 18:1281-1290
11. Nucera C, Porrello A, Antonello ZA, Mekel M, Nehs MA, Giordano TJ, Gerald D, Benjamin LE, Priolo C, Puxeddu E, Finn S, Jarzab B, Hodin RA, Pontecorvi A, Nose V, Lawler J, Parangi S 2010 B-Raf(V600E) and thrombospondin-1 promote thyroid cancer progression. Proc Natl Acad Sci USA 107:10649-10654
12. Burrows N, Babur M, Resch J, Ridsdale S, Mejin M, Rowling EJ, Brabant G, Williams KJ 2011 GDC-0941 inhibits metastatic characteristics of thyroid carcinomas by targeting both the phosphoinositide-3 kinase (PI3K) and hypoxia-inducible factor-1alpha (HIF-1alpha) pathways. J Clin Endocrinol Metab 96:E1934-E1943
13. Nehs MA, Nucera C, Nagarkatti SS, Sadow PM, Morales- Garcia D, Hodin RA, Parangi S 2012 Late intervention with anti-BRAF(V600E) therapy induces tumor regression in an orthotopic mouse model of human anaplastic thyroid cancer. Endocrinology 153:985-994
14. Liu W, Cheng S, Asa SL, Ezzat S 2008 The melanomaassociated antigen A3 mediates fibronectin-controlled cancer progression and metastasis. Cancer Res 68:8104
15. Chan CM, Jing X, Pike LA, Zhou Q, Lim DJ, Sams SB, Lund GS, Sharma V, Haugen BR, Schweppe RE 2012 Targeted inhibition of Src kinase with dasatinib blocks thyroid cancer growth and metastasis. Clin Cancer Res 18:3580-3591
16. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Sherman SI, Tuttle RM 2006 Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:109-142
17. Giordano Attianese GM, Marin V, Hoyos V, Savoldo B, Pizzitola I, Tettamanti S, Agostoni V, Parma M, Ponzoni M, Bertilaccio MT, Ghia P, Biondi A, Dotti G, Biagi E 2011 In vitro and in vivo model of a novel immunotherapy approach for chronic lymphocytic leukemia by anti-CD23 chimeric antigen receptor. Blood 117:4736-4745
18. Teraoka S, Kyoizumi S, Seyama T, Yamakido M, Akiyama M 1994 Scid mice model for the in-vivo study of human oncotherapy - studies on the growth and metastasis of human lung-cancer. Int J Oncol 5:501-508
19. Shultz LD, Lyons BL, Burzenski LM, Gott B, Chen X, Chaleff S, Kotb M, Gillies SD, King M, Mangada J, Greiner DL, Handgretinger R 2005 Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immunol 174:6477-6489
20. Hoelting T, Goretzki PE, Duh QY 2001 Follicular thyroid cancer cells: A model of metastatic tumor in vitro (review). Oncol Rep 8:3-8
21. Nucera C, Nehs MA, Mekel M, Zhang X, Hodin R, Lawler J, Nose V, Parangi S 2009A novel orthotopic mouse model of human anaplastic thyroid carcinoma. Thyroid 19:1077
22. Younes MN, Yigitbasi OG, Park YW, Kim SJ, Jasser SA, Hawthorne VS, Yazici YD, Mandal M, Bekele BN, Bucana CD, Fidler IJ, Myers JN 2005 Antivascular therapy of human follicular thyroid cancer experimental bone metastasis by blockade of epidermal growth factor receptor and vascular growth factor receptor phosphorylation. Cancer Res 65:4716-4727
23. Ahn SH, Henderson Y, Kang Y, Chattopadhyay C, Holton P, Wang M, Briggs K, Clayman GL 2008 An orthotopic model of papillary thyroid carcinoma in athymic nude mice. Arch Otolaryngol Head Neck Surg 134:190-197
24. Fidler IJ, Wilmanns C, Staroselsky A, Radinsky R, Dong Z, Fan D 1994 Modulation of tumor cell response to chemotherapy by the organ environment. Cancer Metastasis Rev 13:209-222
25. Dong Z, Radinsky R, Fan D, Tsan R, Bucana CD, Wilmanns C, Fidler IJ 1994 Organ-specific modulation of steady-state mdr gene expression and drug resistance in murine colon cancer cells. J Natl Cancer Inst 86:913- 920.